SLS - ガリ―ナ・バイオファ―マ (SELLAS Life Sciences Group Inc. ) ガリ―ナ・バイオファ―マ

 SLSのチャート


 SLSの企業情報

symbol SLS
会社名 SELLAS Life Sciences Group Inc (ガリ―ナ・バイオファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 医薬品   医療関連(Health Care)
概要 事業概要 アールエックスアイ・ファーマシューティカルズ(RXi Pharmaceuticals Corporation)はリボ核酸(RNA)干渉(RNAi)を標的とした技術と免疫療法技術を利用して、アンメットメディカルニーズに対処する治療法の発見・開発・商用化に従事するバイオ企業。同社は種々の癌の治療のために、主要な製品候補「NeuVaxtm」を含むペプチドベースの免疫療法製品を活用する癌の治療法、及び標的となる疾患関連遺伝子を発現、或いは発現抑制する自然発生的な細胞メカニズムのRNA干渉(RNAi)に基づいた治療法を追求する。同社の主要な製品は「Herceptin」に不適格の初・中期HER2陽性乳癌患者において乳癌の再発を減少させるペプチドベースの免疫療法「NeuVax」。同社のRNAi製品「RXI-109」は結合組織成長因子を標的とする皮膚抗瘢痕治療法。平成23年4月13日、同社は民間のバイオ企業Apthera Inc. (Apthera)を買収した。   ガリ―ナ・バイオファ―マは、米国のバイオ医薬品企業。癌性疼痛の持続的疼痛管理時の急激な痛み(突出痛)に対して、舌下投与による有効成分フェンタニルの速やかな吸収と鎮痛効果を主薬効とする治療剤アブストラルや、原発性癌の免疫療法の癌の再発の予防のためにNeuVaxを開発。また、婦人科癌、卵巣癌および子宮内膜腺癌で臨床試験の段階の製品もある。   SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapeutics for a broad range of cancer indications. SELLAS' lead product candidate, GPS, is licensed from Memorial Sloan Kettering Cancer Center and targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination to address a broad spectrum of hematologic malignancies and solid tumor indications. SELLAS' second product candidate, NPS, is a HER2-directed cancer immunotherapy with potential for the treatment of patients with early-stage breast cancer with low to intermediate HER2 expression, otherwise known as HER2 1+ or 2+, which includes triple negative breast cancer patients, following standard of care.
本社所在地 15 West 38th Street 10th Floor New York NY 10018 USA
代表者氏名 Angelos M. Stergiou Angelos M. Stergiou
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 917-438-4353
設立年月日 38808
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 11人
url www.sellaslife.com
nasdaq_url https://www.nasdaq.com/symbol/sls
adr_tso
EBITDA EBITDA(百万ドル) -25.27600
終値(lastsale) 1.2864
時価総額(marketcap) 25178151.4752
時価総額 時価総額(百万ドル) 30.53321
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 36.96321
当期純利益 当期純利益(百万ドル) -33.53800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Sellas Life Sciences Group Inc revenues was not reported. Net loss applicable to common stockholders increased 76% to $18.5M. Higher net loss reflects General and administrative - Balancing v increase from $3.8M to $8.7M (expense) Change in fair value of the contingent p increase from $0K to $3.9M (expense) Gain/Loss on Derivatives - Hedging increase from $0K to $727K (expense).

 SLSのテクニカル分析


 SLSのニュース

   Overview of Different Indicators: Evolve Transition Infrastructure LP (AMEX:SNMP), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)  2021/08/01 21:41:02 Stock Equity
Evolve Transition Infrastructure LP (SNMP) with the stream of -10.27% also noticed, India SELLAS Life Sciences Group, Inc. (SLS) encountered a rapid change of -1.50% in the last hour of The post Overview of Different Indicators: Evolve Transition Infrastructure LP (AMEX:SNMP), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) appeared first on Stocks Equity .
   May This Data Fuel Up Investors Confidence? Advanced Micro Devices, Inc. (NASDAQ:AMD), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)  2021/07/30 23:45:03 Stock Equity
Advanced Micro Devices, Inc. (NASDAQ:AMD) with the stream of 3.15% also noticed, India SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) encountered a rapid change of -1.50% in the last hour of The post May This Data Fuel Up Investors Confidence? Advanced Micro Devices, Inc. (NASDAQ:AMD), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) appeared first on Stocks Equity .
   SELLAS Life Sciences to Host Virtual Investor Symposium on its Lead Asset, Galinpepimut-S, on August 17, 2021  2021/07/28 12:30:00 Intrado Digital Media
Management Team to be Joined by Leading Cancer Researcher, Dr. Yair Levy, Director of Hematologic Malignancies at the Baylor University Medical Center, and Member of the REGAL Steering Committee
   Most Active Stock Now: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), BIO-key International, Inc. (NASDAQ:BKYI)  2021/07/22 22:35:35 Stock Equity
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) with the stream of -4.19% also noticed, India BIO-key International, Inc. (NASDAQ:BKYI) encountered a rapid change of 2.12% in the last hour of Thursdays The post Most Active Stock Now: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), BIO-key International, Inc. (NASDAQ:BKYI) appeared first on Stocks Equity .
   Up to Date Stock in Review: Nokia Corporation (NYSE:NOK), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)  2021/07/15 21:09:16 Stock Equity
Nokia Corporation (NOK) with the stream of -2.05% also noticed, India SELLAS Life Sciences Group, Inc. (SLS) encountered a rapid change of 2.38% in the last hour of Thursdays trading The post Up to Date Stock in Review: Nokia Corporation (NYSE:NOK), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) appeared first on Stocks Equity .
   Hooky Stock: ON Semiconductor Corporation (NASDAQ:ON), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)  2021/07/08 02:26:16 Stock Equity
ON Semiconductor Corporation (NASDAQ:ON) with the stream of -2.42% also noticed, India SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) encountered a rapid change of -1.25% in the last hour of Wednesday’s … The post Hooky Stock: ON Semiconductor Corporation (NASDAQ:ON), SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) appeared first on Stocks Equity .
   :   2021/07/07 15:19:30 NewsIt
SELLAS Life Sciences Group, , - - , : galinpepimut-S (GPS) To : NewsIT .
   Active Stock to Observe: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), 22nd Century Group, Inc. (AMEX:XXII)  2021/07/07 00:15:20 Stock Equity
SELLAS Life Sciences Group, Inc. (SLS) with the stream of -0.31% also noticed, India 22nd Century Group, Inc. (XXII) encountered a rapid change of -1.51% in the last hour of The post Active Stock to Observe: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), 22nd Century Group, Inc. (AMEX:XXII) appeared first on Stocks Equity .
   Buy or Sell? What Analysts Recommends: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), GEE Group, Inc. (AMEX:JOB)  2021/07/06 02:29:28 Stock Equity
SELLAS Life Sciences Group, Inc. (SLS) with the stream of -2.47% also noticed, India GEE Group, Inc. (JOB) encountered a rapid change of 5.43% in the last hour of Mondays The post Buy or Sell? What Analysts Recommends: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), GEE Group, Inc. (AMEX:JOB) appeared first on Stocks Equity .
   3   2021/07/05 07:29:10 Zougla
SELLAS Life Sciences Group (NASDAQ: SLS), ,
   Traders Purchase High Volume of SELLAS Life Sciences Group Call Options (AMEX:SLS)  2021/02/03 12:23:10 Modern Readers
SELLAS Life Sciences Group, Inc. (AMEX:SLS) was the target of unusually large options trading on Tuesday. Stock investors purchased 4,526 call options on the company. This is an increase of 1,040% compared to the typical volume of 397 call options. SELLAS Life Sciences Group (AMEX:SLS) last posted its earnings results on Friday, November 13th. The […]
   Why 3 Health Care Stocks Are Moving: Tv Therapeutics, Solid Biosciences, Sellas Life Sciences  2020/12/11 17:33:44 Benzinga
Tv Therapeutics (NASDAQ: VTVT ) shares were trading higher on Friday after the company said its Phase 2 Simplici-T1 study of TTP399 achieved the primary objective of a statistically significant reduction in HbA1c. Tv Therapeutics Inc operates in the United States health care sector. Its key business includes the development of orally administered small molecule drug candidates for the treatment of neurological disorders such as Alzheimer's disease. Tv Therapeutics shares were trading up 52.05% at $3.33 at last check Friday. The stock has a 52-week high of $4.75 and a 52-week low of $1.44. Solid Biosciences (NASDAQ: Full story available on Benzinga.com
   SLS Stock: Here's Why Sellas Life Sciences Is Climbing - CNA Finance  2020/12/10 15:32:15 CNA Finance
SLS stock is screaming for the top in a sympathy play. This is just the beginning with massive potential for gains tomorrow.
   Selbst genäht, gebaut und gebraut  2020/12/01 21:00:00 Volksstimme
Gardelegen l „Mich hat die Neugier hergebracht, da das Geschäft ja zum ersten Mal geöffnet hat“, erzählte Melitta Müller aus Gardelegen im Volksstimme-Gespräch. Sie sei auf der Suche nach einem Geschenk für ihren kleinen Enkel gewesen und wurde am Stand von Linda Wendlandt fündig. Die Gardelegenerin erstand einen Strampler mit passender Mütze und Schal – alles selbst genäht von der jungen Letzlingerin. Und auch deren anderen Angebote von selbstgenähten Taschen, Masken und Tüchern über kleine Schlüsselanhänger mit Einkaufschip und Türstopper in Wichtelform bis hin zu Kissen und bunten Abschminktüchern kamen gut bei den Kunden an. Dabei, erzählt die 32-Jährige lachend, sei sie erst durch Corona zum Nähen gekommen. Da habe sie mehr Zeit gehabt und sich einen Wunsch erfüllt. Im April habe sie ihre erste Nähmaschine gekauft und ganz nach dem Motto „do it yourself“ losgelegt. Mit Anleitungen aus dem Internet habe sie zunächst allerlei ausprobiert. Gestartet ist die Verkäuferin allerdings mit dem, was im Frühjahr außerordentlich wichtig wurde und anfangs Mangelware war, nämlich mit Masken.
   Wo man Pflege trainieren kann  2020/11/18 05:00:00 Kleine Zeitung
Judith Goldgruber leitet die Geriatrie bei den GGZ. Sie freut sich über den Gesundheitspreis "SALUS" für das Albert-Schweitzer-Trainingszentrum.

 関連キーワード  (医薬品 米国株 ガリ―ナ・バイオファ―マ SLS SELLAS Life Sciences Group Inc. )

 twitter  (公式ツイッターやCEOツイッターなど)